Skip to main content

Market Overview

Morgan Stanley's Equity Morning Summary

Share:

Upgrades:
Estacio Participacoes SA (SAO: ESTC3) upgraded from Equal to Overweight, price target remains at $25, 2010 EPS raised to $1.15 (from $1.12), 2011 raised to $1.32 (from $1.15).

Downgrades:
Adobe Systems (NASDAQ: ADBE) downgraded to Equal from Overweight, price target remains at $42.

Boston Scientific (NYSE: BSX) downgraded to Equal from Overweight, price target remains at $10, FY2011 estimates lowered to $0.39 (from $0.43) and for FY2012 to $0.47 (from $0.52).

Dell, Inc (NASDAQ: DELL) downgraded from Equal to Underweight, price target at $11, FY2011 EPS lowered to $1.22 (from $1.24) and FY2012 to $1.34 (from $1.40).

Company Initiations:
Integra LifeSciences (NASDAQ: IART) initiated with an Equal rating and $41 price target. FY2010 estimates at $2.27 and FY2011 at $2.48).

Estimate/Price Target Changes - Up:
Discover Financial Services (NYSE: DFS) maintains Equal rating, price target at $18, new FY2010 estimates at $0.89 (from $0.59), FY2011 to $1.51 (from $1.17).

Estimate/Price Target Changes - Down:
Abbott Laboratories (NYSE: ABT) rating at Overweight, price target lowered to $60 (from $63)

CareFusion Corp. (NYSE: CFN) rating at Overweight, price target lowered to $30 (from $32).

Covidien (NYSE: COV) rating at Overweight, price target lowered to $45 (from $47).

Microsoft Corporation (NASDAQ: MSFT) rating at Overweight, price target lowered to $30 (from $35). FY2011 estimates have been lowered to $2.28 (from $2.35) and for FY2012 lowered to $2.53 (from $2.65).

Sprint Nextel Corporation (NYSE: N) rating at Underweight, price target at $3. FY2010 estimates are at -$1.20 (from -$1.17) and for FY2011 -$0.63 (from -$0.57).

Stryker Corporation (NYSE: SYK) rating at Overweight, price target lowered to $59 from $62.

Estimate/Price Target Changes Up/Down:
National Semiconductor (NYSE: NSM) rating at Equal, FY2011 estimates raised to $1.32 (from $1.29) and for FY2012 lowered to $1.23 (from $1.27).

 

Related Articles (ADBE + ABT)

View Comments and Join the Discussion!

Posted-In: abbott laboratoriesNews Guidance Upgrades Downgrades Price Target Initiation Analyst Ratings

Need corporate guidance data?
Click here to see licensing options.

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com